Intestinal dysbiosis in patients with histamine intolerance

dc.contributor.authorSánchez Pérez, Sònia
dc.contributor.authorComas Basté, Oriol
dc.contributor.authorDuelo, Adriana
dc.contributor.authorVeciana Nogués, María Teresa
dc.contributor.authorBerlanga Herranz, Mercedes
dc.contributor.authorLatorre Moratalla, Mariluz
dc.contributor.authorVidal Carou, Ma. Carmen
dc.date.accessioned2022-05-05T11:38:04Z
dc.date.available2022-05-05T11:38:04Z
dc.date.issued2022-04-26
dc.date.updated2022-05-05T11:38:04Z
dc.description.abstractAn underlying cause of histamine intolerance is diamine oxidase (DAO) deficiency, which leads to defective homeostasis and a higher systemic absorption of histamine. Impaired DAO activity may have a genetic, pharmacological or pathological origin. A recent proposal also suggests it can arise from an alteration in the gut microbiota, although only one study has explored this hypothesis to date. A greater abundance of histamine-secreting bacteria in the gut could lead to the development of histamine intolerance. Thus, the aim of this study was to characterize the composition of the intestinal microbiota of patients with histamine intolerance symptoms and compare it with that of healthy individuals. The study was performed by sequencing bacterial 16S rRNA genes (V3-V4 region) and analyzing the data using the EzBioCloud Database. Dysbiosis of the gut microbiota was observed in the histamine intolerance group who, in comparison with the healthy individuals, had a significantly lower proportion of Prevotellaceae, Ruminococcus, Faecalibacterium and Faecablibacterium prausnitzii, which are bacteria related to gut health. They also had a significantly higher abundance of histaminesecreting bacteria, including the genera Staphylococcus and Proteus, several unidentified genera belonging to the family Enterobacteriaceae and the species Clostridium perfringens and Enterococcus faecalis. A greater abundance of histaminogenic bacteria would favor the accumulation of high levels of histamine in the gut, its subsequent absorption in plasma and the appearance of adverse effects, even in individuals without DAO deficiency.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec723168
dc.identifier.issn2072-6643
dc.identifier.urihttps://hdl.handle.net/2445/185341
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/nu14091774
dc.relation.ispartofNutrients, 2022, num. 14, p. 2 of 14
dc.relation.urihttps://doi.org/10.3390/nu14091774
dc.rightscc-by (c) Sánchez Pérez, Sònia et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Biologia, Sanitat i Medi Ambient)
dc.subject.classificationHistamina
dc.subject.classificationDiamines
dc.subject.classificationNutrició
dc.subject.otherHistamine
dc.subject.otherDiamines
dc.subject.otherNutrition
dc.titleIntestinal dysbiosis in patients with histamine intolerance
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
723168.pdf
Mida:
3.3 MB
Format:
Adobe Portable Document Format

Paquet de llicències

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
license.txt
Mida:
1.71 KB
Format:
Item-specific license agreed upon to submission
Descripció: